🕵️ Ventyx Biosciences, Inc. ($VTYX)
SEC insider & ownership activity, last 12 months · CIK 1851194 · every row links its SEC filing
Over the last 12 months insiders sold $463K with no open-market buying against it. Mohan Raju sold $365K in discretionary trades (Dec). One red-flag 8-K in the window: Delisting notice (3.01), Mar 4, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $463K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Mohan Raju | 0 | – | 1 | $365K | Dec 18, 2025 |
| Nuss John | 0 | – | 1 | $98K | Dec 18, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Somasundaram Subramaniam | 7.6% | 13D | Mar 10, 2025 | filing ↗ | |
| NSV Partners III, L.P. | 6.4% | 13D | Mar 10, 2025 | filing ↗ | |
| Raju Mohan | 6.0% | 13D | Jan 7, 2026 | filing ↗ | |
| Affinity Healthcare Fund, LP | 5.7% | 13G | May 30, 2025 | filing ↗ | |
| The Vanguard Group | 5.3% | 13G | Oct 31, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Mohan Raju | $365K | Dec 18, 2025 | filing ↗ |
| Nuss John | $98K | Dec 18, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Acquisition or disposition (2.01) | Mar 4, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 4, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Mar 4, 2026 | filing ↗ |
| Change of control (5.01) | Mar 4, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 4, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 4, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Other events (8.01) | Feb 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 21, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 22, 2025 | filing ↗ |
| Other events (8.01) | Oct 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 22, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |